MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, SSKN had $1,110K increase in cash & cash equivalents over the period. -$1,082K in free cash flow.

Cash Flow Overview

Change in Cash
$1,110K
Free Cash flow
-$1,082K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-1,398 -4,921
Depreciation and amortization
864 2,438
Amortization of operating lease right-of-use assets
87 172
Amortization of deferred financing costs and debt discount
40 78
Change in allowance for credit losses
-50 166
Stock-based compensation expense
212 257
Loss on disposal of property and equipment
-20 -63
Settlement gains
684 -
Inventory write-off
0 0
Accounts receivable
-568 -1,065
Inventories
-282 912
Prepaid expenses and other assets
84 49
Accounts payable
9 465
Accrued expenses and other liabilities
1 -1,201
Deferred revenues
150 52
Operating lease liabilities
-81 -164
Net cash used in operating activities
-64 -2,491
Purchase of property and equipment
1,018 138
Net cash used in investing activities
-1,018 -138
Payment of contingent consideration
0 0
Sale of common stock, net of offering costs
2,192 -
Net cash provided by financing activities
2,192 0
Net (decrease) increase in cash, cash equivalents and restricted cash
1,110 -2,629
Cash and cash equivalents at beginning of period
8,595 -
Cash and cash equivalents at end of period
7,076 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

STRATA Skin Sciences, Inc. (SSKN)

STRATA Skin Sciences, Inc. (SSKN)